1cP-LSD Dosage Guide

Overdose 1cP-LSD has no known toxic dose. However, higher doses increase the risk of adverse psychological reactions. These reactions include anxiety, delusions and panic attacks. Medical attention is usually not needed except in the case of severe psychotic episodes or the ingestion of fake acid (such as 25i-NBOMe or DOB). Administration of benzodiazepines or antipsychotics can help to relieve the acute negative cognitive effects of 1cP-LSD. Although no formal studies have been conducted, it is assumed that like LSD itself, 1cP-non-addictive with a low abuse potential. There are no literature reports of successful attempts to train animals to self-administer LSD — an animal model predictive of abuse liability — indicating that it does not have the necessary pharmacology to either initiate or maintain dependence. - **Germany:** 1cP-LSD is controlled under the NpSG (*New Psychoactive Substances Act*) as of July 2, 2021. Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized. - **Japan:** 1cP-LSD is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell. - **Sweden:** Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019. - Turkey:** 1cP-LSD is a classed as drug and is illegal to possess, produce, supply, or import. - **United Kingdom:** 1cP-LSD is illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26, 2016. - Responsible use - Research chemicals - Psychedelics - Lysergamides - LSD - 1P-LSD - 1cP-LSD (Wikipedia) - 1-CPA-LSD (Isomer Design) - APA formatted reference Please see the citation formatting guide if you need assistance properly formatting citations. -->